Clinically, overexpression of lncRNAs, like MALAT1, HOTAIR, H19, and UCA1, is associated with lymph node metastasis, advanced staging, and poor survival, making them promising biomarkers and therapeutic targets for managing aggressive HNSCC. This evidence concerns the gene HOTAIR and head and neck squamous cell carcinoma.